Strides Pharma Science Ltd (STAR) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 688428,
    "name": "Strides Pharma",
    "stock_name": "Strides Pharma",
    "full_name": "Strides Pharma Science Ltd",
    "name_url": "stocks-analysis/strides-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,142.05",
    "chg": -11.6,
    "chgp": "-1.01%",
    "dir": -1,
    "prev_price": "1,153.65",
    "mcapval": "10,656.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532531,
    "symbol": "STAR",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE939A01011",
    "curr_date": "May 20",
    "curr_time": "",
    "bse_nse_vol": "6.66 lacs",
    "exc_status": "Active",
    "traded_date": "May 20, 2026",
    "traded_date_str": "2026 05 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/strides-pharma-688428-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/strides-pharma-688428-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Strides Pharma Science Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-strides-pharma-science-ltd-latest-results-good-or-bad-3999533",
        "imagepath": "",
        "date": "2026-05-19 19:19:02",
        "description": "Strides Pharma Science Ltd's latest financial results for Q4 FY26 reflect a company navigating a complex operational landscape. The company achieved net sales of ₹1,323.47 crores, marking a year-on-year growth of 11.18% and indicating strong demand across its markets. This performance represents the highest quarterly revenue in the company's recent history, showcasing effective market penetration.\n\nHowever, the consolidated net profit for the quarter was ₹126.94 crores, which, while showing a year-on-year increase of 54.45%, also reflects a significant sequential decline of 37.19%. This volatility in earnings was primarily driven by a dramatic drop in other income, which fell from ₹106.86 crores in the previous quarter to just ₹8.13 crores, raising concerns about the sustainability of profit levels.\n\nOperating margins, excluding other income, compressed to 18.11% from 19.75% in the prior quarter, highlighti..."
      },
      {
        "title": "Strides Pharma Science Ltd Hits Intraday Low Amid Price Pressure on 19 May 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-hits-intraday-low-amid-price-pressure-on-19-may-2026-3998521",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/StridesPharmaSc_priceRelatedfactors_3998521.png",
        "date": "2026-05-19 09:31:20",
        "description": "Strides Pharma Science Ltd experienced significant intraday weakness on 19 May 2026, with its stock price touching a low of Rs 1,045.8, marking a decline of 9.09% from the previous close. The stock underperformed its sector and broader market indices amid heightened volatility and persistent selling pressure."
      },
      {
        "title": "Strides Pharma Science Ltd Reports Positive Quarterly Performance Amid Financial Trend Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-reports-positive-quarterly-performance-amid-financial-trend-shift-3997634",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/StridesPharmaSc_fintrenddot_3997634.png",
        "date": "2026-05-19 08:00:06",
        "description": "Strides Pharma Science Ltd has demonstrated a commendable financial performance in the quarter ended March 2026, marking a positive shift in its financial trend. The company reported record-high net sales and operating profits, alongside a significant 27.1% growth in net profit after tax, signalling a strengthening position within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Strides Pharma Q4 FY26: Robust Profit Growth Masks Margin Volatility Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/strides-pharma-q4-fy26-robust-profit-growth-masks-margin-volatility-concerns-3997566",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/StridesPharmaSc_quaterlyResult_3997566.png",
        "date": "2026-05-18 21:46:11",
        "description": "Strides Pharma Science Ltd., a mid-tier pharmaceutical manufacturer with a market capitalisation of ₹10,503 crores, delivered a strong fourth quarter performance for FY26, reporting consolidated net profit of ₹126.94 crores—a sequential decline of 37.19% from Q3 FY26's exceptional ₹202.11 crores, but a robust 54.45% year-on-year surge from Q4 FY25's ₹82.19 crores. The stock, trading at ₹1,150.35, has delivered remarkable returns of 74.30% over the past year, significantly outperforming both the Sensex and the pharmaceuticals sector."
      },
      {
        "title": "When is the next results date for Strides Pharma Science Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-strides-pharma-science-ltd-3988152",
        "imagepath": "",
        "date": "2026-05-12 23:16:53",
        "description": "The next results date for Strides Pharma Science Ltd is scheduled for 18 May 2026...."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Strides Pharma Science Ltd to 52-Week High of Rs 1180.45",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-hits-new-52-week-high-at-rs118045-3987491",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/StridesPharmaSc_priceRelatedfactors_3987491.png",
        "date": "2026-05-12 10:35:16",
        "description": "Surging past its previous peaks, Strides Pharma Science Ltd touched a new 52-week high of Rs 1180.45 on 12 May 2026, marking a remarkable 82.62% gain over the past year. This rally stands in stark contrast to the broader market’s subdued performance, with the Sensex down 8.71% over the same period."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Strides Pharma Science Ltd to 52-Week High of Rs 1174.7",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-hits-new-52-week-high-at-rs11747-3985604",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/StridesPharmaSc_priceRelatedfactors_3985604.png",
        "date": "2026-05-11 11:35:14",
        "description": "Surging past Rs 1174.7 on 11 May 2026, Strides Pharma Science Ltd has marked a significant milestone by reaching a fresh 52-week high. This achievement caps an impressive rally of 82.66% over the past year, vastly outperforming the Sensex, which declined by 3.86% in the same period."
      },
      {
        "title": "Strides Pharma Science Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/strides-pharma-science-ltd-is-rated-hold-3984158",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/StridesPharmaSc_mojoScore_3984158.png",
        "date": "2026-05-10 10:10:02",
        "description": "Strides Pharma Science Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Strides Pharma Science Ltd to 52-Week High of Rs 1174",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-hits-new-52-week-high-at-rs1174-3981130",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/StridesPharmaSc_priceRelatedfactors_3981130.png",
        "date": "2026-05-08 09:44:07",
        "description": "Surging to a fresh 52-week high of Rs 1174 on 8 May 2026, Strides Pharma Science Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market despite a subdued Sensex. The stock’s recent rally, marked by a four-day consecutive gain and an 11.9% return in that span, underscores a strong technical alignment that has propelled it well above key moving averages."
      }
    ],
    "total": 688,
    "sid": "688428",
    "stock_news_url": "https://www.marketsmojo.com/news/strides-pharma-science-688428"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "19-May-2026",
      "details": "Newspaper Advertisement - Audited Financial Results for the quarter and financial year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "18-May-2026",
      "details": "Audio Recording of Earnings Call pertaining to the audited Financial Results for the quarter and financial year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Outcome Of Board Meeting Of The Company Held On May 18 2026",
      "datetime": "18-May-2026",
      "details": "Outcome of Board Meeting of the Company held on May 18 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Strides Pharma Science Ltd has declared <strong>40%</strong> dividend, ex-date: 22 Jul 25",
          "dt": "2025-07-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Strides Pharma Science Ltd latest results good or bad?

2026-05-19 19:19:02

Strides Pharma Science Ltd's latest financial results for Q4 FY26 reflect a company navigating a complex operational landscape. The company achieved net sales of ₹1,323.47 crores, marking a year-on-year growth of 11.18% and indicating strong demand across its markets. This performance represents the highest quarterly revenue in the company's recent history, showcasing effective market penetration. However, the consolidated net profit for the quarter was ₹126.94 crores, which, while showing a year-on-year increase of 54.45%, also reflects a significant sequential decline of 37.19%. This volatility in earnings was primarily driven by a dramatic drop in other income, which fell from ₹106.86 crores in the previous quarter to just ₹8.13 crores, raising concerns about the sustainability of profit levels. Operating margins, excluding other income, compressed to 18.11% from 19.75% in the prior quarter, highlighti...

Read full news article

Strides Pharma Science Ltd Hits Intraday Low Amid Price Pressure on 19 May 2026

2026-05-19 09:31:20

Strides Pharma Science Ltd experienced significant intraday weakness on 19 May 2026, with its stock price touching a low of Rs 1,045.8, marking a decline of 9.09% from the previous close. The stock underperformed its sector and broader market indices amid heightened volatility and persistent selling pressure.

Read full news article

Strides Pharma Science Ltd Reports Positive Quarterly Performance Amid Financial Trend Shift

2026-05-19 08:00:06

Strides Pharma Science Ltd has demonstrated a commendable financial performance in the quarter ended March 2026, marking a positive shift in its financial trend. The company reported record-high net sales and operating profits, alongside a significant 27.1% growth in net profit after tax, signalling a strengthening position within the Pharmaceuticals & Biotechnology sector.

Read full news article

Strides Pharma Q4 FY26: Robust Profit Growth Masks Margin Volatility Concerns

2026-05-18 21:46:11

Strides Pharma Science Ltd., a mid-tier pharmaceutical manufacturer with a market capitalisation of ₹10,503 crores, delivered a strong fourth quarter performance for FY26, reporting consolidated net profit of ₹126.94 crores—a sequential decline of 37.19% from Q3 FY26's exceptional ₹202.11 crores, but a robust 54.45% year-on-year surge from Q4 FY25's ₹82.19 crores. The stock, trading at ₹1,150.35, has delivered remarkable returns of 74.30% over the past year, significantly outperforming both the Sensex and the pharmaceuticals sector.

Read full news article

When is the next results date for Strides Pharma Science Ltd?

2026-05-12 23:16:53

The next results date for Strides Pharma Science Ltd is scheduled for 18 May 2026....

Read full news article

Broad-Based Technical Strength Lifts Strides Pharma Science Ltd to 52-Week High of Rs 1180.45

2026-05-12 10:35:16

Surging past its previous peaks, Strides Pharma Science Ltd touched a new 52-week high of Rs 1180.45 on 12 May 2026, marking a remarkable 82.62% gain over the past year. This rally stands in stark contrast to the broader market’s subdued performance, with the Sensex down 8.71% over the same period.

Read full news article

Broad-Based Technical Strength Lifts Strides Pharma Science Ltd to 52-Week High of Rs 1174.7

2026-05-11 11:35:14

Surging past Rs 1174.7 on 11 May 2026, Strides Pharma Science Ltd has marked a significant milestone by reaching a fresh 52-week high. This achievement caps an impressive rally of 82.66% over the past year, vastly outperforming the Sensex, which declined by 3.86% in the same period.

Read full news article

Strides Pharma Science Ltd is Rated Hold

2026-05-10 10:10:02

Strides Pharma Science Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Broad-Based Technical Strength Lifts Strides Pharma Science Ltd to 52-Week High of Rs 1174

2026-05-08 09:44:07

Surging to a fresh 52-week high of Rs 1174 on 8 May 2026, Strides Pharma Science Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market despite a subdued Sensex. The stock’s recent rally, marked by a four-day consecutive gain and an 11.9% return in that span, underscores a strong technical alignment that has propelled it well above key moving averages.

Read full news article

View All News